Dupont Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Dupont Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,529	Closed	-$232K	–	2025
2021 Q3	$232K	Buy	+11,529	New	+$318K	0.01%	1186
2020 Q2	–	Sell	-22,646	Closed	-$416K	–	1448
2020 Q1	$416K	Hold	22,646	–	–	0.01%	735
2019 Q4	$499K	Buy	+22,646	New	+$456K	0.01%	839

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Dupont Capital Management's DRNA Position: Q4 2021 in Review

Dupont Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 11,529 shares — an estimated $232K sold.

Dupont Capital Management first reported a position in DRNA in Q4 2019 and held it in 3 quarters. The position peaked at $499K in Q4 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Dupont Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Dupont Capital Management sold 11,529 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $232K.
Dupont Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 3 quarters.
Dupont Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $499K in Q4 2019.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Dupont Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.